EnsoData
Madison, US · Founded 2015 · Delaware corporation · 7 known investors
Enso Data provides AI-powered analysis of physiological waveforms, particularly sleep studies, to enable clinical diagnosis and patient monitoring. The platform serves clinicians in sleep medicine and related specialties by automating interpretation of medical signals to support proactive patient intervention.
Founders & leadership
JM
Justin MortaraExecutive Officer, Director
SR
Samuel RuskDirector
FR
Frederick RobertsonDirector
SB
Scott ButtonDirector
MD
Matthew D DobereinerExecutive Officer
JR
John RondoniDirector
CF
Christopher FernandezExecutive Officer, Director
BH
Broderick HensenExecutive Officer
MG
Mark GorenbergDirector
SJ
Samuel J. RuskExecutive Officer, Director
CR
Christopher R. FernandezExecutive Officer, Director
Investors · 7
Colle Capital PartnersNew York · $500K – $2M
Great North VenturesMaple Grove
HealthX VenturesMadisonvia Mark Bakken · board
Necessary VenturesSan Francisco · $1M – $2M
Questa CapitalSan Francisco · $15M – $40M
Supermoon CapitalSan Francisco · $150K – $2.5M
Zetta Venture PartnersreportedSan Francisco · $1M – $5Mvia Mark Gorenberg · board
Reported raises · per SEC filings
Form D private placements▶$20MraisedJun 2025 · 7 investors · Other Health CareRule 506(b)
▶$20MraisedJun 2025 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Justin MortaraExecutive Officer, Director
- Samuel RuskDirector
- Frederick RobertsonDirector
- Scott ButtonDirector
- Matthew D DobereinerExecutive Officer
- John RondoniDirector
- Christopher FernandezExecutive Officer, Director
- Broderick HensenExecutive Officer
- Mark GorenbergDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedMay 2022 · 11 investors · Other Health CareRule 506(b)
▶$20MraisedMay 2022 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Justin MortaraDirector
- Mark BakkenDirector
- Broderick HensenExecutive Officer
- Scott ButtonDirector
- Samuel RuskExecutive Officer, Director
- Mark GorenbergDirector
- Christopher FernandezExecutive Officer, Director
- Frederick A. RobertsonDirector
- John RondoniDirector
- Offering amount
- $20M
- Amount sold
- $20M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$9MraisedMay 2020 · 15 investors · Other Health CareRule 506(b)
▶$9MraisedMay 2020 · 15 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Samuel James RuskExecutive Officer, Director
- Victoria GraceDirector
- Christopher Robert FernandezExecutive Officer, Director
- Frederick A. RobertsonDirector
- Mark BakkenDirector
- Offering amount
- $9M
- Amount sold
- $9M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$1.5MraisedMar 2018 · 16 investors · Other TechnologyRule 506(b)
▶$1.5MraisedMar 2018 · 16 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Christopher Robert FernandezExecutive Officer, Director
- Ziad EssaDirector
- Samuel James RuskExecutive Officer, Director
- Mark BakkenDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$275KraisedApr 2016 · 2 investors · Other TechnologyRule 506(b)
▶$275KraisedApr 2016 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Samuel J. RuskExecutive Officer, Director
- Christopher R. FernandezExecutive Officer, Director
- Offering amount
- $550K
- Amount sold
- $275K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.